Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut
06/03/2026 17:11
March 6 (Reuters) - Shares of MiniMed MMED.O, the diabetes business of medical device maker Medtronic MDT.N, opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion. (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Vijay Kishore) ((ArasuKannagi.Basil@thomsonreuters.com;))
Recent news on Medtronic
See all newsStreet View: Medtronic moves from 'show me' story to 'trust the setup' story
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
Medtronic climbs after Q4 results beat estimates